Tipranavir

INDICATIONS

FDA

  • Treatment of HIV+ pts with evidence of viral replication who are highly treatment-experienced or have HIV resistant to multiple PIs.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: January 23, 2023